Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in Depression [Phase 2, Phase 3]

View source ↗

Summary

This entry reports the completion of a Phase 2/3 trial evaluating the efficacy and safety of generic escitalopram in depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Generic escitalopram (escitalopram)

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Depression | Phase 2, Phase 3 | Status: COMPLETED